Digital Mental Health Intervention: Cannabis Clinical Research Insights
This page reviews digital mental health intervention cannabis research insights focusing on a randomized controlled trial of a student-codeveloped app. The study evaluates the effectiveness of app-based support for mental health and substance use…
Cannabinoids in Pediatric Care: Clinical Evidence Review
This review focuses on cannabinoid safety pediatric use, summarizing evidence from 276 studies including interventional and observational research. The clinical evidence supports cautious use of cannabinoids in pediatric medicine for select conditions.…
Cannabidiol & Cortical Excitability: Clinical Trial Evidence
The cannabidiol cortical excitability clinical trial evaluated CBD's direct effects on brain excitability in healthy males. Results showed no significant reduction in cortical excitability, highlighting the importance of drug interactions. This trial…
Cannabinoid Clinical Trials: Cannabis for Student Mental Health
The Minder mobile mental health app was tested in a randomized controlled trial to assess its impact on student mental health and substance use. This digital intervention offers scalable support during the critical transition to higher education. Results…
Endocannabinoid System Research: Cannabis in Mental Health RCTs
This study evaluates a digital mental health intervention designed for university students during a critical transition period. The Minder mobile app, tested in a randomized controlled trial, shows promise in improving mental health and substance use…
Endocannabinoid System Research: Cannabinoids in Pediatrics
Cannabinoids pediatric research is expanding with numerous studies examining safety and efficacy in children. This living systematic review highlights 276 studies across various pediatric conditions. Clinicians should consider this evolving evidence base…
Regulatory Digest: DEA Enforcement & Controlled Substances March 2026
This regulatory digest covers DEA enforcement controlled substances updates relevant to cannabis and synthetic cannabinoid importation. The March 2026 notices highlight scheduling changes and import restrictions. Clinicians should stay informed about…
Daily Digest 2026-03-07: Adolescent Cannabis Psychiatric Outcomes
Recent research highlights adolescent cannabis psychiatric outcomes, emphasizing risks linked to teen cannabis use. The developing brain is vulnerable to cannabis effects, increasing psychiatric disorder risks. This 2026 digest presents new insights into…
Cannabinoid Clinical Trials: GLP-1 Receptors and Mental Health
The GLP-1 receptor agonists mental health study reveals potential protective effects against schizophrenia and other psychiatric conditions. This Mendelian randomization analysis uses genetic proxies to explore causal relationships. Findings suggest…
Medical Cannabis Evidence-Based Care: CBD Autism RCT
This CBD autism clinical trial investigated oral CBD oil effects on social behavior, anxiety, and parental stress in autistic children. The randomized controlled crossover design provided rigorous evidence. Results suggest potential benefits of CBD in…